elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36723903-0E21F2EA-4D0C-4068-89B9-020EDA4B9C89
Q36723903-0E21F2EA-4D0C-4068-89B9-020EDA4B9C89
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36723903-0E21F2EA-4D0C-4068-89B9-020EDA4B9C89
Risk of chemotherapy-induced febrile neutropenia in cancer patients receiving pegfilgrastim prophylaxis: does timing of administration matter?
P2860
Q36723903-0E21F2EA-4D0C-4068-89B9-020EDA4B9C89
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36723903-0E21F2EA-4D0C-4068-89B9-020EDA4B9C89
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8014249ee58501790279e78ff3107a40d2057f72
P2860
Comparison of hospitalization risk and associated costs among patients receiving sargramostim, filgrastim, and pegfilgrastim for chemotherapy-induced neutropenia.